Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,135,394
-
Share change
-
+2,125,394
-
Total reported value
-
$8,807,443
-
Price per share
-
$4.08
-
Number of holders
-
24
-
Value change
-
+$8,671,443
-
Number of buys
-
23
Institutional Holders of MOLECULIN BIOTECH INC - COM (MBRX) as of Q1 2021
As of 31 Mar 2021,
MOLECULIN BIOTECH INC - COM (MBRX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,135,394 shares.
The largest 10 holders included
Sio Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, TRUIST FINANCIAL CORP, Squarepoint Ops LLC, TWO SIGMA SECURITIES, LLC, and Cubist Systematic Strategies, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.